Skip to content

Drug interactions

Siponimod + Sparsentan

Severity: Moderate

Siponimod and Sparsentan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Siponimod is cleared mainly by CYP2C9, and sparsentan is a CYP2C9 inducer. Co-administration may lower siponimod exposure and reduce its effectiveness.

What this interaction means in plain words

Siponimod and Sparsentan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Siponimod belongs to Central Nervous System; Sparsentan belongs to Genitourinary.

Evidence level: Moderate

Why it happens

Sparsentan induces CYP2C9, increasing siponimod metabolism.

What to do

Monitor for loss of multiple sclerosis disease control. Confirm the patient's CYP2C9 genotype is compatible with siponimod and consider alternatives if efficacy declines.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Siponimod and Sparsentan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Siponimod with Sparsentan?

MediHelp rates the interaction as moderate. Siponimod and Sparsentan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Siponimod is cleared mainly by CYP2C9, and sparsentan is a CYP2C9 inducer. Co-administration may lower siponimod exposure and reduce its effectiveness.

How serious is the interaction between Siponimod and Sparsentan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for loss of multiple sclerosis disease control. Confirm the patient's CYP2C9 genotype is compatible with siponimod and consider alternatives if efficacy declines.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in